The UK Competition Appeal Tribunal confirms a pay-for-delay infringement decision but reduces the fines inflicted (GlaxoSmithKline)

On 10 May 2021, the UK's Competition Appeal Tribunal (“CAT”) issued its final decision in GSK (Paroxetine) – the long-running saga concerning pay-for-delay patent settlement agreements between GSK…